They offer plenty of upside and solid dividend growth.
These two blue chip dividend stocks are top buys right now.
Pfizer's new product lineup could allow the pharmaceutical giant to push its dividend steadily higher for another 15 years.
EQNX::TICKER_START (OTCPK:MUSLF),(CSE:MUSL),(NYSE:MRK),(NYSE:PFE),(NASDAQ:MRNA),(NASDAQ:AZN) EQNX::TICKER_END
Check out these healthcare stocks for some healthy payouts.
Income investors tend to gravitate towards covered calls, and blue-chip high yielding stocks are a great place to start.
These great stocks are great picks for investors as spring winds down.
Where there's a will, there's a way. And Pfizer appears to have the will to stake a claim in the massive obesity drug market.
These highly advantaged businesses have what they need to keep raising their dividend payouts.